Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection

World J Gastroenterol. 2012 Jun 21;18(23):2988-94. doi: 10.3748/wjg.v18.i23.2988.

Abstract

Aim: To evaluate the accuracy of specific biochemical markers for the assessment of hepatic fibrosis in patients with chronic hepatitis C virus (HCV) infection.

Methods: One hundred and fifty-four patients with chronic HCV infection were included in this study; 124 patients were non-cirrhotic, and 30 were cirrhotic. The following measurements were obtained in all patients: serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin, total bilirubin, prothrombin time and concentration, complete blood count, hepatitis B surface antigen (HBsAg), HCVAb, HCV-RNA by quantitative polymerase chain reaction, abdominal ultrasound and ultrasonic-guided liver biopsy. The following ratios, scores and indices were calculated and compared with the results of the histopathological examination: AST/ALT ratio (AAR), age platelet index (API), AST to platelet ratio index (APRI), cirrhosis discriminating score (CDS), Pohl score, Göteborg University Cirrhosis Index (GUCI).

Results: AAR, APRI, API and GUCI demonstrated good diagnostic accuracy of liver cirrhosis (80.5%, 79.2%, 76.6% and 80.5%, respectively); P values were: < 0.01, < 0.05, < 0.001 and < 0.001, respectively. Among the studied parameters, AAR and GUCI gave the highest diagnostic accuracy (80.5%) with cutoff values of 1.2 and 1.5, respectively. APRI, API and GUCI were significantly correlated with the stage of fibrosis (P < 0.001) and the grade of activity (P < 0.001, < 0.001 and < 0.005, respectively), while CDS only correlated significantly with the stage of fibrosis (P < 0.001) and not with the degree of activity (P > 0.05). In addition, we found significant correlations for the AAR, APRI, API, GUCI and Pohl score between the non-cirrhotic (F0, F1, F2, F3) and cirrhotic (F4) groups (P values: < 0.001, < 0.05, < 0.001, < 0.001 and < 0.005, respectively; CDS did not demonstrate significant correlation (P > 0.05).

Conclusion: The use of AAR, APRI, API, GUCI and Pohl score measurements may decrease the need for liver biopsies in diagnosing cirrhosis, especially in Egypt, where resources are limited.

Keywords: Age platelet index; Aspartate aminotransferase platelet ratio index; Aspartate aminotransferase-to-alanine aminotransferase ratio; Cirrhosis discriminating score; Fibrosis evaluation; Göteborg University Cirrhosis Index; Hepatitis C virus infection; Liver fibrosis; Pohl score.

MeSH terms

  • Adult
  • Alanine Transaminase / blood
  • Aspartate Aminotransferases / blood
  • Bilirubin / blood
  • Biomarkers / blood
  • Egypt
  • Female
  • Hepacivirus / genetics
  • Hepacivirus / immunology
  • Hepatitis B Surface Antigens / blood
  • Hepatitis C Antibodies / blood
  • Hepatitis C, Chronic / complications*
  • Humans
  • Liver Cirrhosis / blood*
  • Liver Cirrhosis / diagnostic imaging
  • Liver Cirrhosis / pathology*
  • Male
  • Middle Aged
  • Platelet Count
  • Prothrombin / metabolism
  • Prothrombin Time
  • RNA, Viral / blood
  • Serum Albumin / metabolism
  • Ultrasonography

Substances

  • Biomarkers
  • Hepatitis B Surface Antigens
  • Hepatitis C Antibodies
  • RNA, Viral
  • Serum Albumin
  • Prothrombin
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Bilirubin